Compare Aurora Cannabis Inc (ACB) vs iShares Bitcoin Trust (IBIT) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

IBIT trades at $36.12, up 3.58% today, with a bullish technical signal despite bearish moving averages. Key support lies at $35 and resistance at $37. The stock faces headwinds from sector volatility and significant ETF outflows, as reported by Zacks Investment Research on 2026-07-06. Recent news highlights competitive pressures among Bitcoin ETFs, with IBIT leading in assets under management according to The Motley Fool on 2026-06-29.

The outlook remains cautious due to market sentiment shifts and regulatory uncertainties. Investment opportunities hinge on the company's ability to maintain its asset scale advantage, while risks include continued investor outflows and broader crypto market declines impacting related equities.